We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Unique Lipoprotein Phenotype and Genotype Associated With Exceptional Longevity.
- Authors
Barzilai, Nir; Atzmon, Gil; Schechter, Clyde; Schaefer, Ernst J.; Cupples, Adrienne L.; Lipton, Richard; Cheng, Suzanne; Shuldiner, Alan R.
- Abstract
Context: Individuals with exceptional longevity have a lower incidence and/or significant delay in the onset of age-related disease, and their family members may inherit biological factors that modulate aging processes and disease susceptibility. Objective: To identify specific biological and genetic factors that are associated with or reliably define a human longevity phenotype. Design, Setting, and Participants: In a case-control design, 213 Ashkenazi Jewish probands with exceptional longevity (mean [SD] age, 98.2 [5.3] years) and their offspring (n = 216; mean [SD] age, 68.3 [6.7] years) were recruited from 1998 to 2002, while an age-matched control group of Ashkenazi Jews (n = 258) and participants from the Framingham Offspring Study (n = 589) were accepted as control groups. Main Outcome Measures: Detailed questionnaires, physical examination, and blood samples were taken, including assessment of lipids and lipoprotein subclass levels and particle sizes by proton nuclear magnetic resonance. Samples were also genotyped for the codon 405 isoleucine to valine (I405V) variation in the cholesteryl ester transfer protein (CETP) gene, which is involved in regulation of lipoprotein and its particle sizes. Results: High-density lipoprotein (HDL) and low-density lipoprotein (LDL) particle sizes were significantly higher in probands compared with both control groups (P = .001 for both), independent of plasma levels of HDL and LDL cholesterol and apolipoprotein A1 and B. This phenotype was also typical of the proband's offspring but not of the age-matched controls. The HDL and LDL particle sizes were significantly larger in offspring and controls without hypertension or cardiovascular disease, (P = .001 and P = .008, respectively). Furthermore, lipoprotein particle sizes, but not plasma LDL levels, were significantly higher in offspring and controls without the metabolic syndrome (P<.001). Probands and offspring had a 2.9- and 3.6-fold (in men) and 2.7- and 1.5-fold (in...
- Subjects
LONGEVITY; GENETICS; DISEASE susceptibility; ETIOLOGY of diseases; PHENOTYPES; HIGH density lipoproteins; LOW density lipoproteins; ISOPENTENOIDS; AGING; HEALTH outcome assessment
- Publication
JAMA: Journal of the American Medical Association, 2003, Vol 290, Issue 15, p2030
- ISSN
0098-7484
- Publication type
Article
- DOI
10.1001/jama.290.15.2030